Project Number 5R01AG058063-04 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 1. Research Resources and Enabling Technologies to Accelerate Therapy Development b. Translational Bioinformatics and Multi-scale Modeling Researcher and Organization Principal Investigator ALBERS, MARK W Principal Investigator First Name MARK W Principal Investigator Last Name ALBERS Awardee Organization MASSACHUSETTS GENERAL HOSPITAL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-17-032: Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01) FY Overall Cost $748,092 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official YUAN, JEAN Special Initiative Accelerating Medicines Partnership - Alzheimer's Disease (AMP-AD): Target Discovery and Preclinical Validation Project
